Press Releases
Ovid Therapeutics and NeuroPointDX Announce Collaboration to Identify Biomarkers...
Ovid Therapeutics, a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, and NeuroPointDX, a privately...
Press Releases
Capsugel Announces Broad Commercial Availability of MASTâ„¢ System
Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions announced the broad commercial availability of its Modular Automated Sampling Technologyâ„¢ (MAST) system,...
Press Releases
Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish...
Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility in Kirklareli, Turkey. ...
Press Releases
MeiraGTx Awarded Target ALS Grant For Its NMD-Based Therapy...
MeiraGTx, a New York and UK based gene therapy company, announced that it has been awarded a grant from Target ALS, a privately funded foundation...
Press Releases
MDCPartners launches new ta-Scan software that ‘will revolutionize’ the...
MDCPartners  launches ta-Scan 5, an update of its global web-based platform that analyses clinical trial data. The new platform is set to revolutionize the way...
Press Releases
Cyprotex, an Evotec Company, Expands into New UK Facility...
Evotec AG announced that Cyprotex, a company wholly owned by Evotec AG, has completed the relocation of its UK operations from Macclesfield to Alderley Park. ...
Press Releases
Gilead Sciences, Inc. Announces EMA Validation of Marketing Authorization...
Gilead Sciences, Inc announced that the company’s Marketing Authorization Application for the investigational, once-daily, single tablet regimen of sofosbuvir 400 mg. Velpatasvir...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.